文献速递创伤与烧伤重症综合管理与镇静镇痛

创伤性脑损伤后补充短链脂肪酸通过肠-脑-小胶质细胞轴减轻神经损伤

Short-Chain Fatty Acid Supplementation After Traumatic Brain Injury Attenuates Neurologic Injury Via the Gut-Brain-Microglia Axis.
PubMed 文献 · Shock · 2025-09-08
一句话结论小鼠创伤性脑损伤后自由饮用补充乙酸、丁酸、丙酸4周,可减轻神经认知缺陷、减少皮质体积丢失、保留白质连接并调节小胶质细胞转录组。

该研究为小鼠实验,52只14周龄雄性C57BL/6小鼠接受控制性皮质撞击或假损伤,伤后通过饮用水自由摄取乙酸、丁酸、丙酸或等摩尔氯化钠载体4周。结果显示,补充短链脂肪酸(SCFA)减少TBI诱导的微生物丢失、减轻脑室体积丢失、保留白质连接,并改变小胶质细胞转录谱;同时保留产丁酸菌群丰度(P=0.01),降低Clostridiales和Bacteroidales的TBI诱导性增加(P=0.05)。行为学上,SCFA组在零迷宫和旷场中焦虑样行为较载体组改善(P=0.006和P=0.002)。作者认为SCFA补充可能通过直接替代SCFA及肠道产丁酸菌再喂养等机制发挥神经保护作用。

要点

  • 小鼠TBI后自由饮用乙酸、丁酸、丙酸4周,可减轻TBI诱导的微生物丢失并保留产丁酸菌群(P=0.01)。
  • SCFA组TBI小鼠零迷宫焦虑样行为 preserved(152.3±101.8 cm vs 147.5±60.0 cm,P=0.006),旷场中心时间减少(11.7±3% vs 15.0±6%,P=0.002)。
  • SCFA补充减轻TBI后脑室体积丢失、保留白质连接,并上调神经保护性热休克蛋白家族转录本、下调神经退行性相关转录本。
  • 该研究为小鼠实验,SCFA通过饮用水自由摄取,尚未在人体验证。

适用人群与场景

  • 14周龄雄性C57BL/6小鼠(n=52),接受控制性皮质撞击TBI或假损伤。

处置流程与药物剂量

  • TBI后通过饮用水自由摄取乙酸、丁酸、丙酸,持续4周;对照组饮用等摩尔氯化钠载体。

研究设计与关键结果

  • 研究类型:小鼠实验;样本量:52只14周龄雄性C57BL/6小鼠;干预:TBI后自由饮用乙酸、丁酸、丙酸 vs 等摩尔氯化钠载体,持续4周;主要终点结果:SCFA补充减少TBI诱导的微生物丢失、减轻脑室体积丢失、保留白质连接、改变小胶质细胞转录谱;关键次要终点:SCFA组保留产丁酸菌群Firmicutes、Clostridia、Ruminoccacaceae、Peptoccacaceae丰度(P=0.01),降低Clostridiales和Bacteroidales的TBI诱导性增加(P=0.05);零迷宫焦虑样行为:SCFA组152.3±101.8 cm vs 载体组147.5±60.0 cm(P=0.006);旷场中心时间:SCFA组11.7±3% vs 载体组15.0±6%(P=0.002);小胶质细胞转录组:上调神经保护性热休克蛋白家族转录本、下调神经退行性相关转录本。

证据类型、等级与局限

  • 证据类型:动物实验(小鼠);局限:原文未报告局限性。

对床旁实践的改变

  • 该小鼠实验提示TBI后补充短链脂肪酸可能减轻神经认知缺陷、减少皮质体积丢失、保留白质连接并减少神经炎症;作者认为SCFA在微生物组稳态中起作用,膳食干预可能是TBI的新型疗法;尚未在人体验证,不能直接转化为临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Traumatic brain injury (TBI) is an underrecognized public health threat. There are limited therapeutic options for TBI, and supportive care remains the mainstay of treatment. Our previously published data demonstrate that post-TBI fecal microbiome transplantation (FMT) can reverse TBI-induced depletion of commensal bacteria, preserve white matter connectivity and neurocognition, and decrease cortical volume loss in mice after TBI.

HYPOTHESIS: We hypothesized that post-TBI supplementation with short-chain fatty acids (SCFAs), metabolites of commensal gut bacteria, would attenuate neurologic injury after TBI in mice.

METHODS: 14-week-old male C57BL/6 mice ( n = 52) underwent TBI via a controlled cortical impact versus sham injury. Post-TBI, each group was treated with the SCFAs acetate, butyrate, and propionate versus a molar-equivalent sodium chloride vehicle via free access to drinking water for 4 weeks post-TBI. The stool was collected 3 days pre- and 60 days post-TBI to assess the gut microbial community structure via 16s ribosomal RNA gene amplicon sequencing. Neurocognitive testing was performed with open-field and zero-maze testing. Ventricular volume and white matter connectivity were measured with 3D, contrast-enhanced magnetic resonance imaging. Lastly, the transcriptional response of microglia was assessed with single-cell RNA sequencing (scRNAseq).

RESULTS: SCFA supplementation decreased TBI-induced microbial loss, attenuated ventricular volume loss, preserved white matter connectivity, and altered the transcriptional profile of microglia after TBI. Post-TBI SCFA supplementation preserved the abundance of the butyrate-producing taxa Firmicutes, Clostridia, Ruminoccacaceae , and Peptoccacaceae ( P = 0.01). SCFA also reduced the TBI-induced increase in Clostridiales and Bacteroidales compared with the salt vehicle group ( P = 0.05). We also observed the preservation of non-TBI murine anxiety-like behavior in SCFA-treated TBI mice compared with vehicle-treated TBI mice in the zero-maze (152.3 ± 101.8 cm vs. 147.5 ± 60.0 cm, P = 0.006). These results were recapitulated with open-field testing (11.7 ± 3%-time in the center in SCFA-treated TBI mice vs. 15.0 ± 6%-time in the center of the field in vehicle-treated mice; P = 0.002). Lastly, we observed upregulation of transcripts for the neuroprotective heat-shock family of proteins and downregulation of neurodegeneration-associated transcripts, indicating an overall neuroprotective phenotype in microglia after SCFA supplementation post-TBI.

CONCLUSIONS: We hypothesized that SCFA supplementation would attenuate neurologic injury after TBI in mice. SCFA supplementation attenuated neurocognitive deficits, reduced cortical volume loss, preserved white matter connectivity, and decreased neuroinflammation. These benefits may result from the direct replacement of SCFAs. However, there may also be secondary mechanisms related to commensal refeeding of butyrate-producing bacteria within the gut microbial community, a neuroprotective heat-shock response, and a decrease in the expression of genes associated with neurodegeneration. The current study highlights the role of SCFAs in microbiome homeostasis and the potential of dietary intervention as a novel therapy in TBI.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Davis BT, Han H, Islam MBAR, et al. Short-Chain Fatty Acid Supplementation After Traumatic Brain Injury Attenuates Neurologic Injury Via the Gut-Brain-Microglia Axis. Shock. 2025. PMID: 40961414. doi:10.1097/SHK.0000000000002706

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。